These results were consistent with previous studies that high ULBP4 expression could stimulate NK cell and NK-mediated cytotoxicity in vitro [11, 15, 16], which suggested that restoration of ULBP4 expression may be a novel therapeutic strategy for treatment of NPC. Here, RAET1E is linked to nasopharyngeal carcinoma.